|Research Area||To provide funding for novel, high-risk, high-reward, translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.|
|Funding Amount||A maximum of $200,000 over up to 18 months per project.|
|Sponsor||Weston Brain Institute|
There are two stages to the application process: Letters of Intent and Proposals. An application requires the submission of a Letter of Intent which will be reviewed by our scientific review committee. Applicants with high potential projects will then be invited to submit a Proposal. Instructions for submitting the Proposal will be forwarded to those invited in July 2017.
Project Eligibility: Projects must meet two conditions to be eligible,
The Rapid Response program will have multiple calls per year, alternating between two different disease groups (outlined below). Applicants should apply to the group best suited to their project.
Eligible Principal Applicants must be researchers working in Canada at least 30% of the time at or above the level of Postdoctoral Fellow, and affiliated with a Canada Revenue Agency-qualified donee institution located in Canada. If the Principal Applicant is not appointed at the institution from which they are applying, they need to apply with a research supervisor (an “Administrative Supervisor”) at or above the level of Assistant Professor or equivalent, with an appointment at the institution from which they are applying.
More information: http://westonbraininstitute.ca/canada-rapid-response-2017/
Parkinson’s and Related Diseases
LOI Deadline: May 9, 2017
Alzheimer’s and Related Diseases
LOI Deadline: July 5, 2017